Literature DB >> 31243587

Assessment of Myocarditis: Cardiac MR, PET/CT, or PET/MR?

Wengen Chen1, Jean Jeudy2.   

Abstract

PURPOSE OF REVIEW: Diagnosis of myocarditis is challenging given its variable clinical manifestations and non-specific laboratory findings. Cardiac magnetic resonance (MR) is currently the preferred imaging modality for the diagnosis of myocarditis. 18F-fluoro-deoxy-glucose (FDG) positron emission tomography/computed tomography (PET/CT), as a functional imaging tool, has a potential role in the assessment of myocarditis by detecting the underlying myocardial inflammatory activity. Data are accumulating that simultaneous cardiac PET/MR may have complementary and incremental values for the evaluation of myocarditis compared to PET/CT or cardiac MR alone. The article aims to summarize the findings in the literature and discuss future directions of cardiac PET/MR for myocarditis. RECENT
FINDINGS: The Lake Louis Criteria (CLL) of cardiac MR is widely used for the diagnosis of myocarditis. It has an overall acceptable sensitivity of 67% and specificity of 91% for acute myocarditis but does not have the same accuracy for chronic myocarditis. FDG PET/CT is capable of assessing myocarditis by providing metabolic information of inflammation as increased myocardial FDG uptake. In addition to reduced radiation exposure, FDG PET performed on a hybrid PET/MR may detect more myocarditis than FDG PET/CT, because of the delayed PET acquisition time on PET/MR. Case-based observations and small clinical studies of FDG PET/MR have shown that FDG PET findings as abnormally increased myocardial uptake correlate well with the cardiac MR biomarkers. FDG PET findings may add complementary and incremental values to cardiac MR by improving the sensitivity of cardiac MR for mild or borderline myocarditis, and increasing specificity for chronic myocarditis. Preliminary data from retrospective and case-based observational studies have suggested the complementary and incremental values of simultaneous cardiac FDG PET/MR for evaluation of myocarditis, compared to PET/CT or MR alone. Well-designed studies are needed to confirm the findings and to assess the value of cardiac PET/MR for clinical management and more importantly patient's outcome in both acute and chronic myocarditis.

Entities:  

Keywords:  Cardiac; FDG; Inflammation; MR; Myocarditis; PET/CT; PET/MR

Year:  2019        PMID: 31243587     DOI: 10.1007/s11886-019-1158-0

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  47 in total

Review 1.  The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review.

Authors:  A D'Ambrosio; G Patti; A Manzoli; G Sinagra; A Di Lenarda; F Silvestri; G Di Sciascio
Journal:  Heart       Date:  2001-05       Impact factor: 5.994

2.  The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology.

Authors:  Leslie T Cooper; Kenneth L Baughman; Arthur M Feldman; Andrea Frustaci; Mariell Jessup; Uwe Kuhl; Glenn N Levine; Jagat Narula; Randall C Starling; Jeffrey Towbin; Renu Virmani
Journal:  J Am Coll Cardiol       Date:  2007-11-06       Impact factor: 24.094

3.  Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches.

Authors:  Hassan Abdel-Aty; Philipp Boyé; Anja Zagrosek; Ralf Wassmuth; Andreas Kumar; Daniel Messroghli; Petra Bock; Rainer Dietz; Matthias G Friedrich; Jeanette Schulz-Menger
Journal:  J Am Coll Cardiol       Date:  2005-06-07       Impact factor: 24.094

4.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.

Authors:  R J Kim; D S Fieno; T B Parrish; K Harris; E L Chen; O Simonetti; J Bundy; J P Finn; F J Klocke; R M Judd
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

5.  Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy.

Authors:  Michael Jerosch-Herold; David C Sheridan; Jessica D Kushner; Deirdre Nauman; Donna Burgess; Diana Dutton; Rami Alharethi; Duanxiang Li; Ray E Hershberger
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-07-25       Impact factor: 4.733

6.  Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data.

Authors:  Axel Martinez-Möller; Michael Souvatzoglou; Gaspar Delso; Ralph A Bundschuh; Christophe Chefd'hotel; Sibylle I Ziegler; Nassir Navab; Markus Schwaiger; Stephan G Nekolla
Journal:  J Nucl Med       Date:  2009-03-16       Impact factor: 10.057

7.  Suppression of myocardial 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet.

Authors:  Gethin Williams; Gerald M Kolodny
Journal:  AJR Am J Roentgenol       Date:  2008-02       Impact factor: 3.959

8.  Active myocarditis in a patient with chronic active Epstein-Barr virus infection.

Authors:  Hiroyuki Takano; Keiichi Nakagawa; Naoki Ishio; Michiko Daimon; Masao Daimon; Yoshio Kobayashi; Kenzo Hiroshima; Issei Komuro
Journal:  Int J Cardiol       Date:  2007-10-25       Impact factor: 4.164

9.  Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology.

Authors:  Heiko Mahrholdt; Christine Goedecke; Anja Wagner; Gabriel Meinhardt; Anasthasios Athanasiadis; Holger Vogelsberg; Peter Fritz; Karin Klingel; Reinhard Kandolf; Udo Sechtem
Journal:  Circulation       Date:  2004-03-01       Impact factor: 29.690

10.  Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence.

Authors:  Matthias Gutberlet; Birgit Spors; Tobias Thoma; Henriette Bertram; Timm Denecke; Roland Felix; Michel Noutsias; Heinz-Peter Schultheiss; Uwe Kühl
Journal:  Radiology       Date:  2008-01-07       Impact factor: 11.105

View more
  9 in total

1.  Brazilian Society of Cardiology Guideline on Myocarditis - 2022.

Authors:  Marcelo Westerlund Montera; Fabiana G Marcondes-Braga; Marcus Vinícius Simões; Lídia Ana Zytynski Moura; Fabio Fernandes; Sandrigo Mangine; Amarino Carvalho de Oliveira Júnior; Aurea Lucia Alves de Azevedo Grippa de Souza; Bárbara Maria Ianni; Carlos Eduardo Rochitte; Claudio Tinoco Mesquita; Clerio F de Azevedo Filho; Dhayn Cassi de Almeida Freitas; Dirceu Thiago Pessoa de Melo; Edimar Alcides Bocchi; Estela Suzana Kleiman Horowitz; Evandro Tinoco Mesquita; Guilherme H Oliveira; Humberto Villacorta; João Manoel Rossi Neto; João Marcos Bemfica Barbosa; José Albuquerque de Figueiredo Neto; Louise Freire Luiz; Ludhmila Abrahão Hajjar; Luis Beck-da-Silva; Luiz Antonio de Almeida Campos; Luiz Cláudio Danzmann; Marcelo Imbroise Bittencourt; Marcelo Iorio Garcia; Monica Samuel Avila; Nadine Oliveira Clausell; Nilson Araujo de Oliveira; Odilson Marcos Silvestre; Olga Ferreira de Souza; Ricardo Mourilhe-Rocha; Roberto Kalil Filho; Sadeer G Al-Kindi; Salvador Rassi; Silvia Marinho Martins Alves; Silvia Moreira Ayub Ferreira; Stéphanie Itala Rizk; Tiago Azevedo Costa Mattos; Vitor Barzilai; Wolney de Andrade Martins; Heinz-Peter Schultheiss
Journal:  Arq Bras Cardiol       Date:  2022-07       Impact factor: 2.667

Review 2.  Acute myocarditis: aetiology, diagnosis and management.

Authors:  Temi Lampejo; Simon M Durkin; Naman Bhatt; Oliver Guttmann
Journal:  Clin Med (Lond)       Date:  2021-09       Impact factor: 5.410

Review 3.  Diagnostics of messenger ribonucleic acid (mRNA) severe acute respiratory syndrome-corona virus‑2 (SARS-CoV‑2) vaccination-associated myocarditis-A systematic review.

Authors:  Jan M Federspiel; Frank Ramsthaler; Mattias Kettner; Gerhard Mall
Journal:  Rechtsmedizin (Berl)       Date:  2022-07-20       Impact factor: 1.112

Review 4.  Myocarditis Following COVID-19 Vaccination.

Authors:  Constantin A Marschner; Kirsten E Shaw; Felipe Sanchez Tijmes; Matteo Fronza; Sharmila Khullar; Michael A Seidman; Paaladinesh Thavendiranathan; Jacob A Udell; Rachel M Wald; Kate Hanneman
Journal:  Cardiol Clin       Date:  2022-05-06       Impact factor: 2.410

Review 5.  PD-1/PDL-1 Inhibitors and Cardiotoxicity; Molecular, Etiological and Management Outlines.

Authors:  Mohammed Safi; Hyat Ahmed; Mahmoud Al-Azab; Yun-Long Xia; Xiu Shan; Mohammed Al-Radhi; Abdullah Al-Danakh; Abdullah Shopit; Jiwei Liu
Journal:  J Adv Res       Date:  2020-10-03       Impact factor: 10.479

6.  Clone Selection Artificial Intelligence Algorithm-Based Positron Emission Tomography-Computed Tomography Image Information Data Analysis for the Qualitative Diagnosis of Serous Cavity Effusion in Patients with Malignant Tumors.

Authors:  Jing Wei; Pingwei Li; Huai Zhang; Ronghua Zhu
Journal:  J Healthc Eng       Date:  2021-12-18       Impact factor: 2.682

Review 7.  A Review of the Role of Imaging Modalities in the Evaluation of Viral Myocarditis with a Special Focus on COVID-19-Related Myocarditis.

Authors:  Adedayo Adeboye; Deya Alkhatib; Asra Butt; Neeraja Yedlapati; Nadish Garg
Journal:  Diagnostics (Basel)       Date:  2022-02-21

8.  Combined simultaneous FDG-PET/MRI with T1 and T2 mapping as an imaging biomarker for the diagnosis and prognosis of suspected cardiac sarcoidosis.

Authors:  Edward Cheung; Sarah Ahmad; Matthew Aitken; Rosanna Chan; Robert M Iwanochko; Meyer Balter; Ur Metser; Patrick Veit-Haibach; Filio Billia; Yasbanoo Moayedi; Heather J Ross; Kate Hanneman
Journal:  Eur J Hybrid Imaging       Date:  2021-12-16

9.  Ipilimumab- and nivolumab-induced myocarditis in a patient with metastatic cholangiocarcinoma: a case report.

Authors:  Danielle Delombaerde; Delphine Vervloet; Dieter Berwouts; Roel Beckers; Hans Prenen; Marc Peeters; Félix Gremonprez; Lieselot Croes; Christof Vulsteke
Journal:  J Med Case Rep       Date:  2022-07-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.